These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 25709097)

  • 1. Δ9-THC Disrupts Gamma (γ)-Band Neural Oscillations in Humans.
    Cortes-Briones J; Skosnik PD; Mathalon D; Cahill J; Pittman B; Williams A; Sewell RA; Ranganathan M; Roach B; Ford J; D'Souza DC
    Neuropsychopharmacology; 2015 Aug; 40(9):2124-34. PubMed ID: 25709097
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The psychosis-like effects of Δ(9)-tetrahydrocannabinol are associated with increased cortical noise in healthy humans.
    Cortes-Briones JA; Cahill JD; Skosnik PD; Mathalon DH; Williams A; Sewell RA; Roach BJ; Ford JM; Ranganathan M; D'Souza DC
    Biol Psychiatry; 2015 Dec; 78(11):805-13. PubMed ID: 25913109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute effects of Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory evoked mismatch negativity.
    Juckel G; Roser P; Nadulski T; Stadelmann AM; Gallinat J
    Schizophr Res; 2007 Dec; 97(1-3):109-17. PubMed ID: 17884351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-related modulation of event-related potentials to novel and target stimuli by intravenous Δ⁹-THC in humans.
    D'Souza DC; Fridberg DJ; Skosnik PD; Williams A; Roach B; Singh N; Carbuto M; Elander J; Schnakenberg A; Pittman B; Sewell RA; Ranganathan M; Mathalon D
    Neuropsychopharmacology; 2012 Jun; 37(7):1632-46. PubMed ID: 22334121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tetrahydrocannabinol (THC) impairs encoding but not retrieval of verbal information.
    Ranganathan M; Radhakrishnan R; Addy PH; Schnakenberg-Martin AM; Williams AH; Carbuto M; Elander J; Pittman B; Andrew Sewell R; Skosnik PD; D'Souza DC
    Prog Neuropsychopharmacol Biol Psychiatry; 2017 Oct; 79(Pt B):176-183. PubMed ID: 28642081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disruption of frontal θ coherence by Δ9-tetrahydrocannabinol is associated with positive psychotic symptoms.
    Morrison PD; Nottage J; Stone JM; Bhattacharyya S; Tunstall N; Brenneisen R; Holt D; Wilson D; Sumich A; McGuire P; Murray RM; Kapur S; Ffytche DH
    Neuropsychopharmacology; 2011 Mar; 36(4):827-36. PubMed ID: 21150914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabinoid receptor-mediated disruption of sensory gating and neural oscillations: A translational study in rats and humans.
    Skosnik PD; Hajós M; Cortes-Briones JA; Edwards CR; Pittman BP; Hoffmann WE; Sewell AR; D'Souza DC; Ranganathan M
    Neuropharmacology; 2018 Jun; 135():412-423. PubMed ID: 29604295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of chronic cannabinoids on broadband EEG neural oscillations in humans.
    Skosnik PD; D'Souza DC; Steinmetz AB; Edwards CR; Vollmer JM; Hetrick WP; O'Donnell BF
    Neuropsychopharmacology; 2012 Sep; 37(10):2184-93. PubMed ID: 22713908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta-9-tetrahydrocannabinol, neural oscillations above 20 Hz and induced acute psychosis.
    Nottage JF; Stone J; Murray RM; Sumich A; Bramon-Bosch E; Ffytche D; Morrison PD
    Psychopharmacology (Berl); 2015 Feb; 232(3):519-28. PubMed ID: 25038870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separate and combined effects of the cannabinoid agonists nabilone and Δ⁹-THC in humans discriminating Δ⁹-THC.
    Lile JA; Kelly TH; Hays LR
    Drug Alcohol Depend; 2011 Jul; 116(1-3):86-92. PubMed ID: 21227600
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delta(9)-tetrahydrocannabinol, 11-hydroxy-delta(9)-tetrahydrocannabinol and 11-nor-9-carboxy-delta(9)-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids.
    Goodwin RS; Gustafson RA; Barnes A; Nebro W; Moolchan ET; Huestis MA
    Ther Drug Monit; 2006 Aug; 28(4):545-51. PubMed ID: 16885723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disrupted gamma-band neural oscillations during coherent motion perception in heavy cannabis users.
    Skosnik PD; Krishnan GP; D'Souza DC; Hetrick WP; O'Donnell BF
    Neuropsychopharmacology; 2014 Dec; 39(13):3087-99. PubMed ID: 24990428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. It's All in the Rhythm: The Role of Cannabinoids in Neural Oscillations and Psychosis.
    Skosnik PD; Cortes-Briones JA; Hajós M
    Biol Psychiatry; 2016 Apr; 79(7):568-77. PubMed ID: 26850792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Alterations of Auditory Gamma Oscillatory Responses Between Pre-Onset High-Risk Individuals and First-Episode Schizophrenia.
    Tada M; Nagai T; Kirihara K; Koike S; Suga M; Araki T; Kobayashi T; Kasai K
    Cereb Cortex; 2016 Mar; 26(3):1027-1035. PubMed ID: 25452567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of acute oral Delta9-tetrahydrocannabinol and standardized cannabis extract on the auditory P300 event-related potential in healthy volunteers.
    Roser P; Juckel G; Rentzsch J; Nadulski T; Gallinat J; Stadelmann AM
    Eur Neuropsychopharmacol; 2008 Aug; 18(8):569-77. PubMed ID: 18544469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABA Deficits Enhance the Psychotomimetic Effects of Δ9-THC.
    Radhakrishnan R; Skosnik PD; Cortes-Briones J; Sewell RA; Carbuto M; Schnakenberg A; Cahill J; Bois F; Gunduz-Bruce H; Pittman B; Ranganathan M; D'Souza DC
    Neuropsychopharmacology; 2015 Jul; 40(8):2047-56. PubMed ID: 25728472
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of haloperidol on the delta-9-tetrahydrocannabinol response in humans: a responder analysis.
    Gupta S; De Aquino JP; D'Souza DC; Ranganathan M
    Psychopharmacology (Berl); 2019 Sep; 236(9):2635-2640. PubMed ID: 30919005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cannabinoid modulations of resting state EEG θ power and working memory are correlated in humans.
    Böcker KB; Hunault CC; Gerritsen J; Kruidenier M; Mensinga TT; Kenemans JL
    J Cogn Neurosci; 2010 Sep; 22(9):1906-16. PubMed ID: 19803687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction.
    D'Souza DC; Abi-Saab WM; Madonick S; Forselius-Bielen K; Doersch A; Braley G; Gueorguieva R; Cooper TB; Krystal JH
    Biol Psychiatry; 2005 Mar; 57(6):594-608. PubMed ID: 15780846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychomotor performance in relation to acute oral administration of Delta9-tetrahydrocannabinol and standardized cannabis extract in healthy human subjects.
    Roser P; Gallinat J; Weinberg G; Juckel G; Gorynia I; Stadelmann AM
    Eur Arch Psychiatry Clin Neurosci; 2009 Aug; 259(5):284-92. PubMed ID: 19224107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.